Either dietary approach in the trial could lower glucose levels, which could increase the risk of hypoglycemia among individuals using glucose-lowering medications, such as sulfonylureas or insulin, unless appropriate medication adjustments are made. This evidence concerns the gene INS and Hypoglycemia.